search
Back to results

The Neuropsychiatric Evaluation of HIV-Positive and Negative Drug Using Individuals: Study 215

Primary Purpose

HIV Infections

Status
Completed
Phase
Locations
United States
Study Type
Observational
Intervention
Sponsored by
National Institute on Drug Abuse (NIDA)
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an observational trial for HIV Infections focused on measuring HIV Positive

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers
  • Data analysis protocol

Sites / Locations

  • National Institute on Drug Abuse, Biomedical Research Center (BRC)

Outcomes

Primary Outcome Measures

Secondary Outcome Measures

Full Information

First Posted
December 16, 2009
Last Updated
December 16, 2009
Sponsor
National Institute on Drug Abuse (NIDA)
search

1. Study Identification

Unique Protocol Identification Number
NCT01034800
Brief Title
The Neuropsychiatric Evaluation of HIV-Positive and Negative Drug Using Individuals: Study 215
Official Title
The Neuropsychiatric Evaluation of HIV-Positive and Negative Drug Using Individuals: Study 215
Study Type
Observational

2. Study Status

Record Verification Date
January 2009
Overall Recruitment Status
Completed
Study Start Date
September 2006 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
undefined (undefined)

3. Sponsor/Collaborators

Name of the Sponsor
National Institute on Drug Abuse (NIDA)

4. Oversight

5. Study Description

Brief Summary
The lack of success in treating substance abuse may be contributed to by a limited understanding of the clinical neurobiology of drug abuse. A better understanding of such deficits might aid in the development of more relevant pharmacological and psychosocial treatment approaches. Thus, the purpose of this study is to test the hypothesis that repetitive illicit drug use may be associated with cortical and subcortical structural abnormalities, vascular abnormalities, as well as neuropsychological decrements. Additionally, a battery of psychological tests are administered to provide information about demographics, drug use, neurocognitive measures, and personality structures....
Detailed Description
The lack of success in treating substance abuse may be contributed to by a limited understanding of the clinical neurobiology of drug abuse. A better understanding of such deficits might aid in the development of more relevant pharmacological and psychosocial treatment approaches. Thus, the purpose of this study is to test the hypothesis that repetitive illicit drug use may be associated with cortical and subcortical structural abnormalities, vascular abnormalities, as well as neuropsychological decrements. Additionally, a battery of psychological tests are administered to provide information about demographics, drug use, neurocognitive measures, and personality structures.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
HIV Infections
Keywords
HIV Positive

7. Study Design

10. Eligibility

Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Data analysis protocol
Facility Information:
Facility Name
National Institute on Drug Abuse, Biomedical Research Center (BRC)
City
Baltimore
State/Province
Maryland
ZIP/Postal Code
21224
Country
United States

12. IPD Sharing Statement

Learn more about this trial

The Neuropsychiatric Evaluation of HIV-Positive and Negative Drug Using Individuals: Study 215

We'll reach out to this number within 24 hrs